首页 > 最新文献

Journal of Holistic Integrative Pharmacy最新文献

英文 中文
Study on extraction technology and antioxidant activity of "Sibai" extracts based on orthogonal design and Caenorhabditis elegans 基于正交设计和秀丽隐杆线虫的“四白”提取物提取工艺及抗氧化活性研究
Pub Date : 2025-12-01 DOI: 10.1016/j.jhip.2025.11.006
Zhenghao Chen , Haoxian Chen , Xiaohua Ye , Ping Zhao , Yan Wang

Objective

This study examined the antioxidant, whitening, anti-aging, and safety properties of "Sibai" extract obtained from Bombyx Batryticatus, Ampelopsis japonica, Radix Paeoniae Alba, and Atractylodes macrocephala.

Methods

The "Sibai" extract was optimized by orthogonal design and evaluated for in vitro antioxidant activity through hydroxyl radical scavenging, DPPH scavenging, and total reducing capacity measurements. Tyrosinase inhibition and hemolysis assays assessed its whitening potential and biosafety. Anti-aging effects were examined using Caenorhabditis elegans (C. elegans) lifespan and fecundity assays, while antioxidant capacity under H2O2, juglone, and heat stress was evaluated. Motor function was analyzed via head thrashing, body bending, and spontaneous locomotion tests. Finally, aging-related changes in lipofuscin, reactive oxygen species (ROS), malondialdehyde (MDA), and catalase (CAT) levels were measured.

Results

The optimal ratio of Bombyx Batryticatus, Ampelopsis japonica, Radix Paeoniae Alba, and Atractylodes macrocephala rhizome was determined to be 3:3:1:1. At specific concentrations, the extract demonstrated significant biological activity: the scavenging rate for hydroxyl radicals was 61.70% (at 48 ​mg/mL), the scavenging rate for DPPH radicals was 93.53% (at 4 ​mg/mL), and its total reducing power at 48 ​mg/mL was comparable to that of Vitamin C (Vc). The tyrosinase inhibition rate was 74.90% (at 24 ​mg/mL), and the hemolysis rate remained below 15%, indicating good in vitro safety. In lifespan experiments using C. elegans as a model, treatment with 48 ​mg/mL extract reduced fecundity and extended the normal lifespan by 38.5%. Under oxidative stress induced by H2O2 and juglone, as well as under heat stress, the survival time of C. elegans in the 48 ​mg/mL treatment group increased by 37.9%, 69.5%, and 49.2% respectively. In terms of motor ability, the 48 ​mg/mL treatment group showed increases in head thrashing and body bending frequencies by 61.4% and 220.7% respectively, along with excellent autonomous movement capacity. At the cellular level, levels of lipofuscin, ROS, and MDA were reduced by 65.8%, 41.5%, and 51.3% respectively, while CAT activity increased by 329.1%.

Conclusion

This study employed an orthogonal experimental design to determine the optimal formulation. Subsequent validation confirmed that the optimized extract possessed remarkable antioxidant and whitening properties. Furthermore, it was found to significantly enhance stress resistance in C. elegans and improve age-related phenotypes. These results indicated that this formulation may effectively address issues related to aging and oxidative stress.
目的研究从苍术、枇杷、白芍、苍术中提取的“四白”提取物的抗氧化、美白、抗衰老及安全性。方法采用正交设计法对四白提取物进行优化,并通过清除羟基自由基、清除DPPH和总还原能力等指标对其体外抗氧化活性进行评价。酪氨酸酶抑制和溶血试验评价了其美白潜力和生物安全性。通过秀丽隐杆线虫(C. elegans)的寿命和繁殖力测定来检测其抗衰老作用,同时评估H2O2、核桃酮和热应激下的抗氧化能力。通过头部晃动、身体弯曲和自发运动测试来分析运动功能。最后,测量脂褐素、活性氧(ROS)、丙二醛(MDA)和过氧化氢酶(CAT)水平的衰老相关变化。结果确定母蚕、枇杷、白芍、苍术的最佳配比为3:3:1:1。在一定浓度下,其对羟基自由基的清除率为61.70% (48 mg/mL),对DPPH自由基的清除率为93.53% (4 mg/mL),其在48 mg/mL下的总还原力与维生素C (Vc)相当。酪氨酸酶抑制率为74.90% (24 mg/mL),溶血率保持在15%以下,体外安全性较好。在以秀丽隐杆线虫为模型的寿命实验中,48 mg/mL提取物处理降低了繁殖力,延长了正常寿命38.5%。在H2O2和核桃酮诱导的氧化应激和热应激下,48 mg/mL处理组秀丽隐杆线虫的存活时间分别提高了37.9%、69.5%和49.2%。在运动能力方面,48 mg/mL治疗组头部抖动和身体弯曲频率分别增加61.4%和220.7%,自主运动能力良好。在细胞水平上,脂褐素、ROS和MDA水平分别降低了65.8%、41.5%和51.3%,而CAT活性增加了329.1%。结论本研究采用正交试验设计确定最佳处方。随后的验证证实,优化后的提取物具有显著的抗氧化和美白性能。此外,还发现它能显著增强秀丽隐杆线虫的抗逆性,改善年龄相关表型。这些结果表明,该配方可以有效地解决与衰老和氧化应激有关的问题。
{"title":"Study on extraction technology and antioxidant activity of \"Sibai\" extracts based on orthogonal design and Caenorhabditis elegans","authors":"Zhenghao Chen ,&nbsp;Haoxian Chen ,&nbsp;Xiaohua Ye ,&nbsp;Ping Zhao ,&nbsp;Yan Wang","doi":"10.1016/j.jhip.2025.11.006","DOIUrl":"10.1016/j.jhip.2025.11.006","url":null,"abstract":"<div><h3>Objective</h3><div>This study examined the antioxidant, whitening, anti-aging, and safety properties of \"Sibai\" extract obtained from <em>Bombyx Batryticatus</em>, <em>Ampelopsis japonica</em>, <em>Radix Paeoniae Alba</em>, and <em>Atractylodes macrocephala</em>.</div></div><div><h3>Methods</h3><div>The \"Sibai\" extract was optimized by orthogonal design and evaluated for in vitro antioxidant activity through hydroxyl radical scavenging, DPPH scavenging, and total reducing capacity measurements. Tyrosinase inhibition and hemolysis assays assessed its whitening potential and biosafety. Anti-aging effects were examined using <em>Caenorhabditis elegans (C. elegans</em>) lifespan and fecundity assays, while antioxidant capacity under H<sub>2</sub>O<sub>2</sub>, juglone, and heat stress was evaluated. Motor function was analyzed via head thrashing, body bending, and spontaneous locomotion tests. Finally, aging-related changes in lipofuscin, reactive oxygen species (ROS), malondialdehyde (MDA), and catalase (CAT) levels were measured.</div></div><div><h3>Results</h3><div>The optimal ratio of <em>Bombyx Batryticatus</em>, <em>Ampelopsis japonica</em>, <em>Radix Paeoniae Alba</em>, and <em>Atractylodes macrocephala</em> rhizome was determined to be 3:3:1:1. At specific concentrations, the extract demonstrated significant biological activity: the scavenging rate for hydroxyl radicals was 61.70% (at 48 ​mg/mL), the scavenging rate for DPPH radicals was 93.53% (at 4 ​mg/mL), and its total reducing power at 48 ​mg/mL was comparable to that of Vitamin C (Vc). The tyrosinase inhibition rate was 74.90% (at 24 ​mg/mL), and the hemolysis rate remained below 15%, indicating good in vitro safety. In lifespan experiments using <em>C. elegans</em> as a model, treatment with 48 ​mg/mL extract reduced fecundity and extended the normal lifespan by 38.5%. Under oxidative stress induced by H<sub>2</sub>O<sub>2</sub> and juglone, as well as under heat stress, the survival time of <em>C. elegans</em> in the 48 ​mg/mL treatment group increased by 37.9%, 69.5%, and 49.2% respectively. In terms of motor ability, the 48 ​mg/mL treatment group showed increases in head thrashing and body bending frequencies by 61.4% and 220.7% respectively, along with excellent autonomous movement capacity. At the cellular level, levels of lipofuscin, ROS, and MDA were reduced by 65.8%, 41.5%, and 51.3% respectively, while CAT activity increased by 329.1%.</div></div><div><h3>Conclusion</h3><div>This study employed an orthogonal experimental design to determine the optimal formulation. Subsequent validation confirmed that the optimized extract possessed remarkable antioxidant and whitening properties. Furthermore, it was found to significantly enhance stress resistance in <em>C. elegans</em> and improve age-related phenotypes. These results indicated that this formulation may effectively address issues related to aging and oxidative stress.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 4","pages":"Pages 398-406"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A key pathological change in early stage ankylosing spondylitis: cartilage dyshomeostasis induced by Osteogenic Progenitor Cells 早期强直性脊柱炎的一个关键病理改变:成骨祖细胞诱导的软骨平衡失调
Pub Date : 2025-12-01 DOI: 10.1016/j.jhip.2025.11.002
Yuxin Cai , Liyan Li , Xiaoyan Du , Jun Chen , Kai-Kei Miu , Yujie Deng , Li Lu

Objective

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, with symptoms of back pain and stiffness partially explained by pathophysiological events encompassing enthesitis, ectopic bone formation, and cartilage degeneration. Progressive fusion of vertebrae leading to reduced mobility is a prominent character of AS, but there remain many unknowns regarding bone pathology, in particular abnormal bone outgrowth. This study aims to elucidate the cellular and molecular mechanisms that underpin pathological osteogenesis in the AS.

Methods

We conducted a 3-year longitudinal study on cynomolgus monkeys with spontaneous ankylosing spondylitis, which included performing imaging examinations, H&E, Masson, IHC staining, and bone histomorphometric analysis. These methods were employed to clarify the pathological features of different stages of AS and to explore the pathological mechanisms leading to pathological ossification.

Results

In the spines of AS-afflicted cynomolgus monkeys, early pathological features included inflammatory infiltration, invasion of cartilage endplates by fibrous-rich granulation tissue, and erosion cavities in the cartilage endplates, all of which were highly spatiotemporally correlated with the formation of ectopic new bone. After acute inflammation, fibroblasts in the granulation tissue underwent osteoblastic differentiation to form woven bone, which was presumed as the primary process of syndesmophyte formation in AS. The appearance of erosion cavities in cartilage endplates marked the onset of disrupted endplate homeostasis. Pathological reductions were observed in the thickness of the ligaments, subchondral bone plates, hypertrophic cell layers, and intervertebral disc height within the lumbar joints. In the later stages, ectopic cartilage ossification and ectopic fibrous ossification together contributed to syndesmophyte formation, such that the cartilage endplate almost completely disappeared, leading to joint ankylosis. At the cell level, accumulated cells within the early cartilage endplate erosion cavities were confirmed to be bone marrow-derived osteoprogenitor cells, whereas the abnormal expression of BMP-2 signaling in the locality promoted bone remodeling in AS.

Conclusion

This study provides a pathological analysis of spinal joints in AS-afflicted cynomolgus monkeys, summarizing the pathological features during the progression of AS. It demonstrates that bone marrow-derived osteoprogenitor cells initiate cartilage ossification and likely revealed an unknown mechanism for AS ossification. These findings offer new insights into the skeletal pathology of AS to inform future direction for devising therapeutic approaches to combat AS.
强直性脊柱炎(AS)是一种主要影响脊柱和骶髂关节的慢性炎症性疾病,其背部疼痛和僵硬的症状部分可以通过包括椎体炎、异位骨形成和软骨变性在内的病理生理事件来解释。椎体进行性融合导致活动能力降低是AS的一个突出特征,但关于骨病理,特别是异常骨生长,仍有许多未知因素。本研究旨在阐明AS病理性成骨的细胞和分子机制。方法对自发性强直性脊柱炎食食猴进行了为期3年的纵向研究,包括影像学检查、H&;E、Masson、免疫组化染色和骨组织形态学分析。通过这些方法来明确AS不同阶段的病理特征,探讨导致病理性骨化的病理机制。结果食蟹猴as患者脊柱早期病理表现为炎症浸润、富含纤维的肉芽组织侵袭软骨终板、软骨终板糜烂空腔,与异位新骨的形成具有高度的时空相关性。急性炎症后,肉芽组织中的成纤维细胞进行成骨细胞分化形成编织骨,这被认为是as综合征形成的主要过程。软骨终板糜烂腔的出现标志着终板内环境平衡被破坏的开始。腰关节内的韧带厚度、软骨下骨板厚度、肥大细胞层和椎间盘高度均出现病理性减少。在后期,异位软骨骨化和异位纤维骨化共同促进了副骨的形成,使软骨终板几乎完全消失,导致关节强直。在细胞水平上,早期软骨终板侵蚀腔内积累的细胞被证实是骨髓来源的骨祖细胞,而局部BMP-2信号的异常表达促进了AS的骨重塑。结论本研究对AS发病的食蟹猴脊柱关节进行了病理分析,总结了AS发展过程中的病理特征。这表明,骨髓来源的骨祖细胞启动软骨骨化,并可能揭示了未知的AS骨化机制。这些发现为AS的骨骼病理学提供了新的见解,为设计治疗方法提供了未来的方向。
{"title":"A key pathological change in early stage ankylosing spondylitis: cartilage dyshomeostasis induced by Osteogenic Progenitor Cells","authors":"Yuxin Cai ,&nbsp;Liyan Li ,&nbsp;Xiaoyan Du ,&nbsp;Jun Chen ,&nbsp;Kai-Kei Miu ,&nbsp;Yujie Deng ,&nbsp;Li Lu","doi":"10.1016/j.jhip.2025.11.002","DOIUrl":"10.1016/j.jhip.2025.11.002","url":null,"abstract":"<div><h3>Objective</h3><div>Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, with symptoms of back pain and stiffness partially explained by pathophysiological events encompassing enthesitis, ectopic bone formation, and cartilage degeneration. Progressive fusion of vertebrae leading to reduced mobility is a prominent character of AS, but there remain many unknowns regarding bone pathology, in particular abnormal bone outgrowth. This study aims to elucidate the cellular and molecular mechanisms that underpin pathological osteogenesis in the AS.</div></div><div><h3>Methods</h3><div>We conducted a 3-year longitudinal study on cynomolgus monkeys with spontaneous ankylosing spondylitis, which included performing imaging examinations, H&amp;E, Masson, IHC staining, and bone histomorphometric analysis. These methods were employed to clarify the pathological features of different stages of AS and to explore the pathological mechanisms leading to pathological ossification.</div></div><div><h3>Results</h3><div>In the spines of AS-afflicted cynomolgus monkeys, early pathological features included inflammatory infiltration, invasion of cartilage endplates by fibrous-rich granulation tissue, and erosion cavities in the cartilage endplates, all of which were highly spatiotemporally correlated with the formation of ectopic new bone. After acute inflammation, fibroblasts in the granulation tissue underwent osteoblastic differentiation to form woven bone, which was presumed as the primary process of syndesmophyte formation in AS. The appearance of erosion cavities in cartilage endplates marked the onset of disrupted endplate homeostasis. Pathological reductions were observed in the thickness of the ligaments, subchondral bone plates, hypertrophic cell layers, and intervertebral disc height within the lumbar joints. In the later stages, ectopic cartilage ossification and ectopic fibrous ossification together contributed to syndesmophyte formation, such that the cartilage endplate almost completely disappeared, leading to joint ankylosis. At the cell level, accumulated cells within the early cartilage endplate erosion cavities were confirmed to be bone marrow-derived osteoprogenitor cells, whereas the abnormal expression of BMP-2 signaling in the locality promoted bone remodeling in AS.</div></div><div><h3>Conclusion</h3><div>This study provides a pathological analysis of spinal joints in AS-afflicted cynomolgus monkeys, summarizing the pathological features during the progression of AS. It demonstrates that bone marrow-derived osteoprogenitor cells initiate cartilage ossification and likely revealed an unknown mechanism for AS ossification. These findings offer new insights into the skeletal pathology of AS to inform future direction for devising therapeutic approaches to combat AS.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 4","pages":"Pages 491-503"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145840728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Banxia Shumi decoction targets ribosome biogenesis to alleviate insomnia 半夏舒密汤通过核糖体生物发生缓解失眠
Pub Date : 2025-12-01 DOI: 10.1016/j.jhip.2025.11.001
Xijian Liu, Xiangye Gao, Suyu Hou, Dandan Luo, Yan Zhang

Objective

This study aims to investigate the novel mechanism by which Banxia Shumi Decoction (BXSM) alleviates insomnia through the regulation of ribosome biogenesis (Ribosis).

Methods

We identified the molecular targets associated with the components of BXSM utilizing multiple databases, including PharmMapper and SwissTargetPrediction. Furthermore, we analyzed differentially expressed genes (DEG) linked to insomnia from the GSE 208668 dataset and compiled genes associated with Ribosis from existing literature. A protein interaction network was then constructed to pinpoint the central hub gene related to Ribosis. Additionally, various analytical approaches were employed, including Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and immune infiltration analysis, to explore the relevant functional implications of the identified genes. The validations were performed using operating characteristic (ROC) analysis, Gene Expression Omnibus dataset, quantitative real-time polymerase chain reaction (qRT-PCR), molecular docking, and molecular dynamics simulation.

Results

KAT2B was recognized as the key target, daidzin, naringin, aescin, kaempferol, and apigenin bind stably with KAT2B. Notably, KAT2B was primarily involved in various pathways, including the thyroid hormone signaling pathway. ROC assessment indicated that KAT2B exhibited high accuracy in distinguishing individuals with insomnia. Compared with the model group, BXSM could significantly upregulate the mRNA expression of KAT2B, and downregulate the mRNA expression level of THRB, MYC, and PGC-1α (P ​< ​0.01).

Conclusion

This study elucidates the potential mechanisms by which BXSM ameliorates insomnia through its core bioactive compounds (daidzin, naringin, aescin, kaempferol, and apigenin). These compounds target KAT2B to modulate the thyroid hormone signaling pathway, which in turn regulates Ribosis.
目的探讨半夏舒密汤通过调节核糖体生物发生(Ribosis)减轻失眠的新机制。方法利用多个数据库(PharmMapper和SwissTargetPrediction)鉴定与BXSM成分相关的分子靶点。此外,我们分析了GSE 208668数据集中与失眠相关的差异表达基因(DEG),并从现有文献中编译了与Ribosis相关的基因。然后构建了一个蛋白质相互作用网络,以确定与核糖分裂相关的中心枢纽基因。此外,采用基因集富集分析(GSEA)、基因本体分析(GO)、京都基因与基因组百科全书(KEGG)途径富集分析和免疫浸润分析等多种分析方法,探讨鉴定基因的相关功能意义。通过工作特征(ROC)分析、Gene Expression Omnibus数据集、定量实时聚合酶链反应(qRT-PCR)、分子对接和分子动力学模拟进行验证。结果确认KAT2B为关键靶点,大豆苷元、柚皮苷元、七叶皂苷元、山奈酚、芹菜素与KAT2B结合稳定。值得注意的是,KAT2B主要参与多种途径,包括甲状腺激素信号通路。ROC评估显示KAT2B在区分失眠症个体方面具有较高的准确性。与模型组比较,BXSM显著上调KAT2B mRNA表达,下调THRB、MYC、PGC-1α mRNA表达水平(P < 0.01)。结论本研究阐明了黄芪丹参通过其核心生物活性成分(大豆苷元、柚皮苷元、七叶皂苷、山奈酚和芹菜素)改善失眠的可能机制。这些化合物以KAT2B为靶点调节甲状腺激素信号通路,进而调节核糖分裂。
{"title":"Banxia Shumi decoction targets ribosome biogenesis to alleviate insomnia","authors":"Xijian Liu,&nbsp;Xiangye Gao,&nbsp;Suyu Hou,&nbsp;Dandan Luo,&nbsp;Yan Zhang","doi":"10.1016/j.jhip.2025.11.001","DOIUrl":"10.1016/j.jhip.2025.11.001","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to investigate the novel mechanism by which Banxia Shumi Decoction (BXSM) alleviates insomnia through the regulation of ribosome biogenesis (Ribosis).</div></div><div><h3>Methods</h3><div>We identified the molecular targets associated with the components of BXSM utilizing multiple databases, including PharmMapper and SwissTargetPrediction. Furthermore, we analyzed differentially expressed genes (DEG) linked to insomnia from the GSE 208668 dataset and compiled genes associated with Ribosis from existing literature. A protein interaction network was then constructed to pinpoint the central hub gene related to Ribosis. Additionally, various analytical approaches were employed, including Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and immune infiltration analysis, to explore the relevant functional implications of the identified genes. The validations were performed using operating characteristic (ROC) analysis, Gene Expression Omnibus dataset, quantitative real-time polymerase chain reaction (qRT-PCR), molecular docking, and molecular dynamics simulation.</div></div><div><h3>Results</h3><div>KAT2B was recognized as the key target, daidzin, naringin, aescin, kaempferol, and apigenin bind stably with KAT2B. Notably, KAT2B was primarily involved in various pathways, including the thyroid hormone signaling pathway. ROC assessment indicated that KAT2B exhibited high accuracy in distinguishing individuals with insomnia. Compared with the model group, BXSM could significantly upregulate the mRNA expression of KAT2B, and downregulate the mRNA expression level of THRB, MYC, and PGC-1α (<em>P</em> ​&lt; ​0.01).</div></div><div><h3>Conclusion</h3><div>This study elucidates the potential mechanisms by which BXSM ameliorates insomnia through its core bioactive compounds (daidzin, naringin, aescin, kaempferol, and apigenin). These compounds target KAT2B to modulate the thyroid hormone signaling pathway, which in turn regulates Ribosis.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 4","pages":"Pages 373-388"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145652047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of solvent composition, concentration, and temperature on the solubility of naproxen: A review of mono-solvent, binary, and ternary systems 溶剂组成、浓度和温度对萘普生溶解度的影响:单溶剂、二元和三元体系综述
Pub Date : 2025-12-01 DOI: 10.1016/j.jhip.2025.12.004
Abdolhamid Khodadadi , Shirin Boghrat , Zahra Besharati , Seyed Hossein Hashemi
Solubility is a key factor affecting drug absorption and therapeutic effectiveness. Naproxen, a common anti-inflammatory medication, has poor water solubility, which limits its bioavailability. This review thoroughly explores various solvent-based approaches to overcome this issue. It discusses mono-solvent systems (acetone, chloroform, β-cyclodextrins), binary systems (ethanol, PEG, PG, deep eutectic solvents), and ternary systems that combine water with co-solvents and additives like HPβCD and L-arginine. The review also assesses advanced techniques such as supercritical CO2 and CO2-expanded solvents. Findings show that solvent type, hydrogen bonding ability, and molecular interactions play crucial roles in improving solubility. Ternary systems exhibit notable synergistic effects, and deep eutectic solvents present promising eco-friendly alternatives. In conclusion, careful selection and combination of solvents can significantly enhance naproxen's solubility, guiding future research toward optimizing formulations for pharmaceutical and industrial uses.
溶解度是影响药物吸收和治疗效果的关键因素。萘普生是一种常见的消炎药,它的水溶性很差,这限制了它的生物利用度。这篇综述深入探讨了各种基于溶剂的方法来克服这个问题。它讨论了单溶剂体系(丙酮、氯仿、β-环糊精),二元体系(乙醇、PEG、PG、深共晶溶剂),以及将水与共溶剂和添加剂(如HPβCD和l -精氨酸)结合的三元体系。该综述还评估了超临界二氧化碳和二氧化碳膨胀溶剂等先进技术。结果表明,溶剂类型、氢键能力和分子相互作用对提高溶解度起着至关重要的作用。三元体系表现出显著的协同效应,深共晶溶剂是有前途的环保替代品。综上所述,溶剂的精心选择和组合可以显著提高萘普生的溶解度,指导未来研究优化药物和工业用途的配方。
{"title":"The impact of solvent composition, concentration, and temperature on the solubility of naproxen: A review of mono-solvent, binary, and ternary systems","authors":"Abdolhamid Khodadadi ,&nbsp;Shirin Boghrat ,&nbsp;Zahra Besharati ,&nbsp;Seyed Hossein Hashemi","doi":"10.1016/j.jhip.2025.12.004","DOIUrl":"10.1016/j.jhip.2025.12.004","url":null,"abstract":"<div><div>Solubility is a key factor affecting drug absorption and therapeutic effectiveness. Naproxen, a common anti-inflammatory medication, has poor water solubility, which limits its bioavailability. This review thoroughly explores various solvent-based approaches to overcome this issue. It discusses mono-solvent systems (acetone, chloroform, β-cyclodextrins), binary systems (ethanol, PEG, PG, deep eutectic solvents), and ternary systems that combine water with co-solvents and additives like HPβCD and L-arginine. The review also assesses advanced techniques such as supercritical CO<sub>2</sub> and CO<sub>2</sub>-expanded solvents. Findings show that solvent type, hydrogen bonding ability, and molecular interactions play crucial roles in improving solubility. Ternary systems exhibit notable synergistic effects, and deep eutectic solvents present promising eco-friendly alternatives. In conclusion, careful selection and combination of solvents can significantly enhance naproxen's solubility, guiding future research toward optimizing formulations for pharmaceutical and industrial uses.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 4","pages":"Pages 427-442"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145799733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review on the extraction, separation, purification, detection of flavonoids from aging Citri Reticulatae Pericarpium and its beneficial effects on spleen deficiency 陈化柑桔皮黄酮的提取、分离、纯化、检测及其对脾虚的有益作用综述
Pub Date : 2025-12-01 DOI: 10.1016/j.jhip.2025.12.001
Leixi Ye , Le Yu , Hongjie Xu , Kunyi Liu , Yunqi Shan , Quan Yang , Xiaoming Sun
Citri Reticulatae Pericarpium (CRP) plays beneficial effects on regulating Qi and strengthening spleen, drying dampness, and resolving phlegm in traditional Chinese medicine. This review centered on the advantageous impacts of flavonoids regarding spleen deficiency as well as their extraction, separation, and purification procedures, aiming to disclose the characteristics manifested in spleen deficiency conditions. The existing literature has not merely shed light on the therapeutic mechanisms underlying CRP flavonoids within the digestive tract, but has also highlighted their cooperative and amplifying impacts on other organs. By integrating these diverse strands of research, a more in-depth understanding of the pharmacological actions of CRP has emerged, providing a fresh theoretical framework for deciphering the scientific significance of aged CRP.
柑桔网皮(CRP)在中药中具有调气健脾、燥湿化痰的功效。本文综述了黄酮类化合物对脾虚的有利作用及其提取、分离和纯化方法,旨在揭示脾虚的特点。现有的文献不仅阐明了c反应蛋白类黄酮在消化道内的治疗机制,而且还强调了它们对其他器官的合作和放大作用。通过整合这些不同的研究,对CRP的药理作用有了更深入的了解,为解读衰老CRP的科学意义提供了一个新的理论框架。
{"title":"A review on the extraction, separation, purification, detection of flavonoids from aging Citri Reticulatae Pericarpium and its beneficial effects on spleen deficiency","authors":"Leixi Ye ,&nbsp;Le Yu ,&nbsp;Hongjie Xu ,&nbsp;Kunyi Liu ,&nbsp;Yunqi Shan ,&nbsp;Quan Yang ,&nbsp;Xiaoming Sun","doi":"10.1016/j.jhip.2025.12.001","DOIUrl":"10.1016/j.jhip.2025.12.001","url":null,"abstract":"<div><div>Citri Reticulatae Pericarpium (CRP) plays beneficial effects on regulating Qi and strengthening spleen, drying dampness, and resolving phlegm in traditional Chinese medicine. This review centered on the advantageous impacts of flavonoids regarding spleen deficiency as well as their extraction, separation, and purification procedures, aiming to disclose the characteristics manifested in spleen deficiency conditions. The existing literature has not merely shed light on the therapeutic mechanisms underlying CRP flavonoids within the digestive tract, but has also highlighted their cooperative and amplifying impacts on other organs. By integrating these diverse strands of research, a more in-depth understanding of the pharmacological actions of CRP has emerged, providing a fresh theoretical framework for deciphering the scientific significance of aged CRP.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 4","pages":"Pages 415-426"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An integrative framework for precision medication in hypertension: Applying a dialectical perspective to traditional Chinese and Western medicine 高血压精准治疗的整合框架:辨证视角下的中西医结合
Pub Date : 2025-09-01 DOI: 10.1016/j.jhip.2025.09.001
Jinliang Liu , Jiena Xiao , Zhongwei Lin , Mingzhu Xiao
Hypertension is the most common cardiovascular disease. In terms of diagnosis and treatment, Traditional Chinese Medicine (TCM) and Western medicine each have their own strengths, but also have certain limitations. Affected by the combined effects of genetic and environmental factors, the pharmacotherapy of hypertension shows significant individual differences. Therefore, how to integrate the advantages of TCM and Western medicine to achieve precision medication has become an important research topic. A single diagnostic and therapeutic model is difficult to take into account both the characteristics of TCM's "holistic regulation" and Western medicine's "precision intervention": TCM focuses on holistic syndrome differentiation and the restoration of bodily balance, yet it is relatively vague in the analysis of disease mechanisms and the identification of drug targets; Western medicine excels in targeted therapy, but often overlooks the patient's overall physiological state and the holistic progression of the disease. In the current development of precision medication, the concept of integrative pharmacy provides important support. By systematically integrating multi-source knowledge and technical means, it is committed to combining the macro-holistic perspective with micro-precision intervention, and provides a practical framework for the integration and innovation of TCM and Western medicine. Against this background, TCM takes "holistic concept" and "syndrome differentiation and treatment" as its fundamentals, and devotes itself to maintaining the dynamic balance of human body functions; Western medicine, relying on advanced tools such as genomics and proteomics, emphasizes the precise identification of etiologies and targeted therapy. The two show a dialectical unity in concepts and methods, and jointly serve the realization of the goal of individualized treatment for hypertension. With "principle, method, prescription, and medicine" as the logical main line, this paper systematically explores the diagnostic and therapeutic ideas and practical strategies of TCM and Western medicine for hypertension, and expounds on how to take integrative pharmacy as a bridge to incorporate the holistic thinking of TCM into the modern precision medication system, thereby providing theoretical references and practical paths for promoting the integrated diagnosis and treatment of hypertension with TCM and Western medicine and the implementation of precise drug intervention.
高血压是最常见的心血管疾病。在诊断和治疗方面,中医和西医各有优势,但也有一定的局限性。受遗传和环境因素的共同影响,高血压的药物治疗存在显著的个体差异。因此,如何整合中西医优势,实现精准用药成为一个重要的研究课题。单一的诊疗模式难以兼顾中医“整体调节”和西医“精准干预”的特点:中医注重整体辨证和身体平衡的恢复,但在疾病机制的分析和药物靶点的确定上相对模糊;西医擅长靶向治疗,但往往忽视了患者的整体生理状态和疾病的整体进展。在当前精准医疗的发展中,结合药学的理念提供了重要的支撑。通过系统整合多源知识和技术手段,致力于将宏观整体视角与微观精准干预相结合,为中西医融合创新提供实践框架。在此背景下,中医以“整体观”和“辨证论治”为基础,致力于维持人体功能的动态平衡;西医依靠基因组学和蛋白质组学等先进工具,强调病因的精确鉴定和靶向治疗。两者在观念和方法上表现出辩证统一,共同为实现个体化治疗高血压的目标服务。本文以“理、法、方、药”为逻辑主线,系统探讨了中西医对高血压的诊疗思路和实践策略,阐述了如何以中西医结合为桥梁,将中医整体思维融入现代精准医疗体系。从而为推动中西医结合诊治高血压,实施精准药物干预提供理论参考和实践路径。
{"title":"An integrative framework for precision medication in hypertension: Applying a dialectical perspective to traditional Chinese and Western medicine","authors":"Jinliang Liu ,&nbsp;Jiena Xiao ,&nbsp;Zhongwei Lin ,&nbsp;Mingzhu Xiao","doi":"10.1016/j.jhip.2025.09.001","DOIUrl":"10.1016/j.jhip.2025.09.001","url":null,"abstract":"<div><div>Hypertension is the most common cardiovascular disease. In terms of diagnosis and treatment, Traditional Chinese Medicine (TCM) and Western medicine each have their own strengths, but also have certain limitations. Affected by the combined effects of genetic and environmental factors, the pharmacotherapy of hypertension shows significant individual differences. Therefore, how to integrate the advantages of TCM and Western medicine to achieve precision medication has become an important research topic. A single diagnostic and therapeutic model is difficult to take into account both the characteristics of TCM's \"holistic regulation\" and Western medicine's \"precision intervention\": TCM focuses on holistic syndrome differentiation and the restoration of bodily balance, yet it is relatively vague in the analysis of disease mechanisms and the identification of drug targets; Western medicine excels in targeted therapy, but often overlooks the patient's overall physiological state and the holistic progression of the disease. In the current development of precision medication, the concept of integrative pharmacy provides important support. By systematically integrating multi-source knowledge and technical means, it is committed to combining the macro-holistic perspective with micro-precision intervention, and provides a practical framework for the integration and innovation of TCM and Western medicine. Against this background, TCM takes \"holistic concept\" and \"syndrome differentiation and treatment\" as its fundamentals, and devotes itself to maintaining the dynamic balance of human body functions; Western medicine, relying on advanced tools such as genomics and proteomics, emphasizes the precise identification of etiologies and targeted therapy. The two show a dialectical unity in concepts and methods, and jointly serve the realization of the goal of individualized treatment for hypertension. With \"principle, method, prescription, and medicine\" as the logical main line, this paper systematically explores the diagnostic and therapeutic ideas and practical strategies of TCM and Western medicine for hypertension, and expounds on how to take integrative pharmacy as a bridge to incorporate the holistic thinking of TCM into the modern precision medication system, thereby providing theoretical references and practical paths for promoting the integrated diagnosis and treatment of hypertension with TCM and Western medicine and the implementation of precise drug intervention.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 3","pages":"Pages 290-300"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative network pharmacology and transcriptomics suggest the mechanism of Buyang Huanwu Decoction in attenuating vascular aging via AMPK signaling pathway 综合网络药理学和转录组学提示补阳还五汤通过AMPK信号通路减缓血管衰老的机制
Pub Date : 2025-09-01 DOI: 10.1016/j.jhip.2025.09.004
Xuejuan Shen , Jieyong Du , Xiangyu Chen , Xiaodie Chen , Nan Xiao , Danping Huang , Yubin Yang , Rong Chen , Zunpeng Shu , Li Zhang

Objective

Vascular aging is a critical factor in cardiovascular diseases. Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, shows potential in delaying vascular aging, yet its mechanisms remain unclear. This study aims to explore BYHWD's pharmacological mechanisms through integrative network pharmacology and transcriptomics.

Methods

Network pharmacology identified BYHWD targets related to aging, followed by pathway enrichment analysis. Vascular histopathology was evaluated using HE, Masson, and EVG staining. Senescence biomarkers SA-β-gal, advanced glycation end products (AGEs), p16, p21, and p53 were determined. Oxidative-inflammatory markers were quantified via ELISA and RT-qPCR. Transcriptomic profiling used Illumina NovaSeq. AMP-activated protein kinase (AMPK) signaling pathway analysis employed immunohistochemistry.

Results

Network pharmacology identified 103 key targets, including SIRT1 and AMPK, related to oxidative stress and inflammation. In the D-galactose-induced aging model rats, BYHWD treatment significantly reduced vascular media thickness by 28% in the medium-dose group, collagen deposition, and markers of senescence, such as SA-β-gal, AGEs, p16, p21, and p53. Transcriptomics revealed AMPK signaling pathway enrichment, and further experiments revealed that BYHWD mediates its effects involving activation of the AMPK/Sirt1/Foxo3a axis, a key regulator of vascular homeostasis.

Conclusion

BYHWD may attenuate vascular aging by AMPK-mediated regulation of oxidative stress and inflammation, providing a novel multi-target strategy against age-related cardiovascular diseases. The underlying molecular mechanism still needs to be further clarified.
目的:血管老化是心血管疾病发生的重要因素。补阳还五汤(BYHWD)是一种中药,具有延缓血管衰老的潜力,但其机制尚不清楚。本研究旨在通过综合网络药理学和转录组学的方法来探讨BYHWD的药理机制。方法网络药理学鉴定出BYHWD与衰老相关的靶点,并进行通路富集分析。采用HE、Masson和EVG染色评价血管组织病理学。测定衰老生物标志物SA-β-gal、晚期糖基化终产物(AGEs)、p16、p21和p53。通过ELISA和RT-qPCR定量检测氧化炎症标志物。转录组学分析使用Illumina NovaSeq。免疫组织化学分析amp活化蛋白激酶(AMPK)信号通路。结果网络药理学鉴定出103个与氧化应激和炎症相关的关键靶点,包括SIRT1和AMPK。在d -半乳糖诱导的衰老模型大鼠中,BYHWD治疗显著减少了中剂量组28%的血管介质厚度、胶原沉积和衰老标志物,如SA-β-gal、AGEs、p16、p21和p53。转录组学显示AMPK信号通路富集,进一步的实验表明BYHWD介导其作用涉及激活AMPK/Sirt1/Foxo3a轴,这是血管稳态的关键调节因子。结论byhwd可能通过ampk介导的氧化应激和炎症调节来减缓血管衰老,为治疗年龄相关性心血管疾病提供了一种新的多靶点策略。其潜在的分子机制仍需进一步阐明。
{"title":"Integrative network pharmacology and transcriptomics suggest the mechanism of Buyang Huanwu Decoction in attenuating vascular aging via AMPK signaling pathway","authors":"Xuejuan Shen ,&nbsp;Jieyong Du ,&nbsp;Xiangyu Chen ,&nbsp;Xiaodie Chen ,&nbsp;Nan Xiao ,&nbsp;Danping Huang ,&nbsp;Yubin Yang ,&nbsp;Rong Chen ,&nbsp;Zunpeng Shu ,&nbsp;Li Zhang","doi":"10.1016/j.jhip.2025.09.004","DOIUrl":"10.1016/j.jhip.2025.09.004","url":null,"abstract":"<div><h3>Objective</h3><div>Vascular aging is a critical factor in cardiovascular diseases. Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine, shows potential in delaying vascular aging, yet its mechanisms remain unclear. This study aims to explore BYHWD's pharmacological mechanisms through integrative network pharmacology and transcriptomics.</div></div><div><h3>Methods</h3><div>Network pharmacology identified BYHWD targets related to aging, followed by pathway enrichment analysis. Vascular histopathology was evaluated using HE, Masson, and EVG staining. Senescence biomarkers SA-<em>β</em>-gal, advanced glycation end products (AGEs), p16, p21, and p53 were determined. Oxidative-inflammatory markers were quantified via ELISA and RT-qPCR. Transcriptomic profiling used Illumina NovaSeq. AMP-activated protein kinase (AMPK) signaling pathway analysis employed immunohistochemistry.</div></div><div><h3>Results</h3><div>Network pharmacology identified 103 key targets, including SIRT1 and AMPK, related to oxidative stress and inflammation. In the D-galactose-induced aging model rats, BYHWD treatment significantly reduced vascular media thickness by 28% in the medium-dose group, collagen deposition, and markers of senescence, such as SA-<em>β</em>-gal, AGEs, p16, p21, and p53. Transcriptomics revealed AMPK signaling pathway enrichment, and further experiments revealed that BYHWD mediates its effects involving activation of the AMPK/Sirt1/Foxo3a axis, a key regulator of vascular homeostasis.</div></div><div><h3>Conclusion</h3><div>BYHWD may attenuate vascular aging by AMPK-mediated regulation of oxidative stress and inflammation, providing a novel multi-target strategy against age-related cardiovascular diseases. The underlying molecular mechanism still needs to be further clarified.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 3","pages":"Pages 276-289"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mendelian randomization analysis establishes a causal relationship between COVID-19 and cardiometabolic diseases 孟德尔随机化分析建立了COVID-19与心脏代谢疾病之间的因果关系
Pub Date : 2025-09-01 DOI: 10.1016/j.jhip.2025.08.001
Haibo Chen , Lizhen Liao , Zezhi Ke , Xu Zhang , Xiaodong Zhuang , Xin Gao , Litao Pan

Objective

The causal impacts of COVID-19 on cardiometabolic diseases remained uncertain. This study utilized the two-sample Mendelian randomization (MR) method to evaluate causal relationships between COVID-19 (susceptibility and severity) and four primary cardiometabolic diseases (type 2 diabetes, coronary heart disease, ischemic stroke, and heart failure).

Methods

MR analysis was conducted using genome-wide association study (GWAS) results. Susceptibility and severity were defined as COVID-19-positive and COVID-19-hospitalization, respectively. Data from the COVID-19 Host Genetics Initiative were used for susceptibility and severity analysis. Consortium data from Spracklen CN, Nikpay, Malik R, and Neale lab were employed for type 2 diabetes, coronary heart disease, ischemic stroke, and heart failure, respectively.

Results

For COVID-19 susceptibility, the inverse variance weighted (IVW) method showed the odds ratio (OR) (95% confidence interval [CI], P-value) for type 2 diabetes was 1.719 (1.510–1.956, P ​= ​0.000). For COVID-19 severity, the IVW method estimate indicated that the OR (95% CI, P-value) for ischemic stroke was 1.051 (1.008–1.095, P ​= ​0.020). Moreover, the OR for heart failure was slightly higher in the hospitalized population than in the control population (1.001, 95% CI 1.000–1.002, P ​= ​0.010). The remaining results were negative.

Conclusion

This MR study establishes that genetically predicted COVID-19 susceptibility causally increases type 2 diabetes risk, while severe infection shows suggestive causal links with ischemic stroke and heart failure, redefining COVID-19 as an independent cardiometabolic risk factor.
目的COVID-19对心脏代谢疾病的因果影响尚不确定。本研究采用双样本孟德尔随机化(MR)方法评估COVID-19(易感性和严重程度)与四种原发性心脏代谢疾病(2型糖尿病、冠心病、缺血性中风和心力衰竭)之间的因果关系。方法采用全基因组关联研究(GWAS)结果进行smr分析。易感性和严重程度分别定义为covid -19阳性和covid -19住院。来自COVID-19宿主遗传学计划的数据用于易感性和严重性分析。来自Spracklen CN、Nikpay、Malik R和Neale实验室的联盟数据分别用于2型糖尿病、冠心病、缺血性中风和心力衰竭。结果对于COVID-19易感性,逆方差加权(IVW)方法显示2型糖尿病的优势比(OR)(95%可信区间[CI], P值)为1.719 (1.510 ~ 1.956,P = 0.000)。对于COVID-19严重程度,IVW方法估计显示缺血性卒中的OR (95% CI, P值)为1.051 (1.008-1.095,P = 0.020)。此外,住院人群的心力衰竭OR略高于对照组(1.001,95% CI 1.000-1.002, P = 0.010)。其余的结果都是否定的。这项MR研究证实,基因预测的COVID-19易感性会增加2型糖尿病的风险,而严重感染与缺血性卒中和心力衰竭有暗示的因果关系,重新定义了COVID-19作为一个独立的心脏代谢危险因素。
{"title":"Mendelian randomization analysis establishes a causal relationship between COVID-19 and cardiometabolic diseases","authors":"Haibo Chen ,&nbsp;Lizhen Liao ,&nbsp;Zezhi Ke ,&nbsp;Xu Zhang ,&nbsp;Xiaodong Zhuang ,&nbsp;Xin Gao ,&nbsp;Litao Pan","doi":"10.1016/j.jhip.2025.08.001","DOIUrl":"10.1016/j.jhip.2025.08.001","url":null,"abstract":"<div><h3>Objective</h3><div>The causal impacts of COVID-19 on cardiometabolic diseases remained uncertain. This study utilized the two-sample Mendelian randomization (MR) method to evaluate causal relationships between COVID-19 (susceptibility and severity) and four primary cardiometabolic diseases (type 2 diabetes, coronary heart disease, ischemic stroke, and heart failure).</div></div><div><h3>Methods</h3><div>MR analysis was conducted using genome-wide association study (GWAS) results. Susceptibility and severity were defined as COVID-19-positive and COVID-19-hospitalization, respectively. Data from the COVID-19 Host Genetics Initiative were used for susceptibility and severity analysis. Consortium data from Spracklen CN, Nikpay, Malik R, and Neale lab were employed for type 2 diabetes, coronary heart disease, ischemic stroke, and heart failure, respectively.</div></div><div><h3>Results</h3><div>For COVID-19 susceptibility, the inverse variance weighted (IVW) method showed the odds ratio (OR) (95% confidence interval [CI], <em>P</em>-value) for type 2 diabetes was 1.719 (1.510–1.956, <em>P</em> ​= ​0.000). For COVID-19 severity, the IVW method estimate indicated that the OR (95% CI, P-value) for ischemic stroke was 1.051 (1.008–1.095, <em>P</em> ​= ​0.020). Moreover, the OR for heart failure was slightly higher in the hospitalized population than in the control population (1.001, 95% CI 1.000–1.002, <em>P</em> ​= ​0.010). The remaining results were negative.</div></div><div><h3>Conclusion</h3><div>This MR study establishes that genetically predicted COVID-19 susceptibility causally increases type 2 diabetes risk, while severe infection shows suggestive causal links with ischemic stroke and heart failure, redefining COVID-19 as an independent cardiometabolic risk factor.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 3","pages":"Pages 301-307"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145120795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking artemisinin's potential in polycystic ovary syndrome treatment: A call for controlled human trials 释放青蒿素治疗多囊卵巢综合征的潜力:呼吁进行对照人体试验
Pub Date : 2025-09-01 DOI: 10.1016/j.jhip.2025.09.009
Osama Ahmad , Komal Zulfiqar
{"title":"Unlocking artemisinin's potential in polycystic ovary syndrome treatment: A call for controlled human trials","authors":"Osama Ahmad ,&nbsp;Komal Zulfiqar","doi":"10.1016/j.jhip.2025.09.009","DOIUrl":"10.1016/j.jhip.2025.09.009","url":null,"abstract":"","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 3","pages":"Pages 322-323"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145219991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization, characterization, hypoglycemic and antioxidant activity studies of ultrasonic-assisted deep eutectic solvent extraction of polysaccharides from Perilla frutescens 超声辅助深共晶溶剂提取紫苏多糖的优化、表征、降糖及抗氧化活性研究
Pub Date : 2025-09-01 DOI: 10.1016/j.jhip.2025.09.008
Jiajian Tang, Zilin Cong, Huijia Dai, Sigui Zhou, Yao Wen

Objective

In order to further develop and utilise Perilla frutescens polysaccharides, the aim of this study was to optimize process conditions for the extraction of Perilla frutescens polysaccharides with deep eutectic solvents (DES), to investigate their biological activities and to analyse their monosaccharide composition.

Methods

Perilla frutescens polysaccharides were extracted by DES and ultrasonic extraction, and the optimal extraction process was obtained by one-way test and response surface method. The extract was collected and concentrated, alcohol precipitated, deproteinized, dialyzed, and evaporated to make a solution, which was purified by DEAE and Sephadex G-75 columns to obtain the arginal polysaccharide PFP-1.

Results

The polysaccharide was extracted from Perilla frutescens by ultrasonication with the aid of a new type of DES, and the optimal conditions for extraction were determined: the optimal DES system for extracting the polysaccharide of Perilla frutescens and the molar ratio was choline chloride: oxalic acid ​= ​2:1; ultrasonication temperature, power, and time were 70 ​°C, 280 ​W, and 45 ​min, respectively; and the liquid-solid ratio was 21 ​mL/g, and the extraction rate of polysaccharide was 2.44%. The molecular weight (Mw) of PFP-1 is approximately 11600 ​Da. Hydrolysis and derivatization of the refined polysaccharide PFP-1 followed by analytical experiments determined that the polysaccharide monosaccharides consisted of rhamnose, glucuronic acid, and glucose, with the molar ratios of 1.45: 2.82: 1.41. The antioxidant activity and hypoglycemic activity of the polysaccharide were determined to be good by free radical scavenging and enzyme inhibition experiments, and the IC50 of Perilla frutescens polysaccharide against DPPH• was 0.117 ​mg/mL and that against α-amylase was 0.002 ​mg/mL.

Conclusion

This study can provide an experimental basis for the establishment of an industrialized production process of polysaccharides and the study of their biological activities.
目的为了进一步开发利用紫苏多糖,对紫苏多糖的深度共熔溶剂(DES)提取工艺条件进行优化,考察其生物活性,并对其单糖组成进行分析。方法采用分光光度法和超声提取法提取枸杞多糖,通过单向试验和响应面法确定最佳提取工艺。收集提取液浓缩、醇沉、去蛋白、透析、蒸发成溶液,经DEAE和Sephadex G-75柱纯化,得到原始多糖PFP-1。结果利用新型DES对紫苏多糖进行超声提取,确定了提取紫苏多糖的最佳DES体系,其摩尔比为氯化胆碱:草酸= 2:1;超声温度70℃,功率280 W,时间45 min;液料比为21 mL/g,多糖提取率为2.44%。PFP-1的分子量(Mw)约为11600 Da。对精制多糖PFP-1进行水解衍生化分析实验,确定多糖单糖由鼠李糖、葡萄糖醛酸和葡萄糖组成,摩尔比为1.45:2.82:1.41。通过自由基清除和酶抑制实验确定紫苏多糖具有良好的抗氧化和降糖活性,紫苏多糖对DPPH•的IC50为0.117 mg/mL,对α-淀粉酶的IC50为0.002 mg/mL。结论本研究可为多糖工业化生产工艺的建立及生物活性的研究提供实验依据。
{"title":"Optimization, characterization, hypoglycemic and antioxidant activity studies of ultrasonic-assisted deep eutectic solvent extraction of polysaccharides from Perilla frutescens","authors":"Jiajian Tang,&nbsp;Zilin Cong,&nbsp;Huijia Dai,&nbsp;Sigui Zhou,&nbsp;Yao Wen","doi":"10.1016/j.jhip.2025.09.008","DOIUrl":"10.1016/j.jhip.2025.09.008","url":null,"abstract":"<div><h3>Objective</h3><div>In order to further develop and utilise <em>Perilla frutescens</em> polysaccharides, the aim of this study was to optimize process conditions for the extraction of <em>Perilla frutescens</em> polysaccharides with deep eutectic solvents (DES), to investigate their biological activities and to analyse their monosaccharide composition.</div></div><div><h3>Methods</h3><div><em>Perilla frutescens</em> polysaccharides were extracted by DES and ultrasonic extraction, and the optimal extraction process was obtained by one-way test and response surface method. The extract was collected and concentrated, alcohol precipitated, deproteinized, dialyzed, and evaporated to make a solution, which was purified by DEAE and Sephadex G-75 columns to obtain the arginal polysaccharide PFP-1.</div></div><div><h3>Results</h3><div>The polysaccharide was extracted from <em>Perilla frutescens</em> by ultrasonication with the aid of a new type of DES, and the optimal conditions for extraction were determined: the optimal DES system for extracting the polysaccharide of <em>Perilla frutescens</em> and the molar ratio was choline chloride: oxalic acid ​= ​2:1; ultrasonication temperature, power, and time were 70 ​°C, 280 ​W, and 45 ​min, respectively; and the liquid-solid ratio was 21 ​mL/g, and the extraction rate of polysaccharide was 2.44%. The molecular weight (<em>Mw</em>) of PFP-1 is approximately 11600 ​Da. Hydrolysis and derivatization of the refined polysaccharide PFP-1 followed by analytical experiments determined that the polysaccharide monosaccharides consisted of rhamnose, glucuronic acid, and glucose, with the molar ratios of 1.45: 2.82: 1.41. The antioxidant activity and hypoglycemic activity of the polysaccharide were determined to be good by free radical scavenging and enzyme inhibition experiments, and the IC<sub>50</sub> of <em>Perilla frutescens</em> polysaccharide against DPPH• was 0.117 ​mg/mL and that against <em>α</em>-amylase was 0.002 ​mg/mL.</div></div><div><h3>Conclusion</h3><div>This study can provide an experimental basis for the establishment of an industrialized production process of polysaccharides and the study of their biological activities.</div></div>","PeriodicalId":100787,"journal":{"name":"Journal of Holistic Integrative Pharmacy","volume":"6 3","pages":"Pages 333-342"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145265019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Holistic Integrative Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1